首页> 外文会议>IEEE Global Humanitarian Technology Conference >Development of Smartband to Monitor from Home the Vital Signs for Patients with SARS COV 2 Through a Mobile Application from the Central Military Hospital (HOMIL) Bogota 2020
【24h】

Development of Smartband to Monitor from Home the Vital Signs for Patients with SARS COV 2 Through a Mobile Application from the Central Military Hospital (HOMIL) Bogota 2020

机译:通过中央军事医院(Homil)Bogota 2020的移动应用,从家中从家中监测SARS COV 2患者的重要标志

获取原文

摘要

After the arrival of SARS COV2 (COVID 19) many biomedical devices have been innovated to mitigate the impact of the pandemic. Despite this, none have been developed to monitor patients with mild symptoms or the asymptomatic from their homes, forcing many hospitals worldwide to send these patients home with poor surveillance measures. The main objective of this project is to monitor from the HOMIL the vital signs of COVID 19 patients, who are currently isolated in their homes. For this purpose, a biomedical device in the form of a lowcost smartband has been developed. It is linked to a mobile application connected to a database where heart rate, oxygen saturation, and temperature parameters are sent in real time. The development was proposed in phases, which involve physical design, data acquisition and processing, and subsequent trial at the HOMIL. The smartband design and the mobile application has been developed, wireless communication between sensors has been achieved. Furthermore, the plan is to provide the HOMIL with the capability of initiating emergency protocols. The use of the smartband will be encouraged in patients who have tested positive for COVID 19 through PCR and will be taken off once they test negative.
机译:在SARS COV2(Covid 19)到达后,许多生物医学设备已经创新以减轻大流行的影响。尽管如此,没有人开发出监测症状轻度症状或从家的症状的患者,迫使世界各地的许多医院派遣这些患者家庭的监视措施。该项目的主要目标是从Homil监测Covid 19名患者的重要迹象,目前被隔绝在家中。为此目的,已经开发出低音智能带形式的生物医学装置。它与连接到心率,氧饱和度和温度参数的数据库的移动应用程序相关联。该开发是在阶段提出的,涉及物理设计,数据采集和处理,以及随后在HOMIL的试验。已经开发了智能带设计和移动应用程序,已经实现了传感器之间的无线通信。此外,该计划是提供HOMIL以启动紧急协议的能力。将鼓励使用智能带的患者对Covid 19通过PCR进行阳性的患者,并将在其测试中进行消极的。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号